Dual-Metal Organic Framework Nanozyme for Synergistic Photothermal-Chemodynamic Therapy: Copper-Molybdenum Synergism in Gastric Cancer Treatment
International Journal of Nanomedicine · 2026-06 · Volume 21 · 1-16
DOI: 10.2147/ijn.s592877 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-06. Verfasst von Dachuan Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Copper, Molybdenum, Metal-Organic Frameworks. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To address the dual challenges of chemotherapy toxicity and poor tumor microenvironment regulation in gastric cancer, we developed a copper-molybdenum bimetallic organic framework nanozyme (CMP) that integrates chemodynamic therapy (CDT) and photothermal therapy (PTT). The system leverages synergistic reactive oxygen species (ROS) generation and localized hyperthermia to deliver efficient, low-toxicity treatment. Methods: ) into copper-based MOF pores via hydrothermal reaction. Physicochemical properties were characterized using transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS). Systematic evaluation of antitumor efficacy and biosafety was conducted through in vitro assays (CCK-8, calcein-AM/PI staining, ROS detection) and in vivo xenograft models (subcutaneous implantation of NCI-N87 cells in BALB/c nude mice).
Results
The CMP nanozyme demonstrated exceptional photothermal conversion efficiency (29.4% under 808 nm laser). In vitro experiments revealed significant cytotoxicity with ROS elevation. In vivo studies showed significant tumor growth inhibition without hematotoxicity (WBC, ALT levels showed no statistical significance vs. controls). Histopathology confirmed extensive tumor necrosis with preserved cytoarchitecture in vital organs (heart, liver, spleen, and kidney).
Conclusion
The CMP nanozyme achieves potent antitumor efficacy through photothermal-enhanced Fenton-like reactions, depleting glutathione and amplifying ROS. It suppresses gastric cancer in vivo with minimal systemic toxicity, representing a promising nanoplatform for precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
- Graduate School of Medical School of Chinese PLA Hospital, Beijing, 100853, People's Republic of China.
- Nankai University, Tianjin, 300071, People's Republic of China.
Zitieren
APA
Sun, D., Linghu, B., Lu, C., & Wei, B. (2026). Dual-Metal Organic Framework Nanozyme for Synergistic Photothermal-Chemodynamic Therapy: Copper-Molybdenum Synergism in Gastric Cancer Treatment. International Journal of Nanomedicine, Volume 21, 1-16. https://doi.org/10.2147/ijn.s592877
Vancouver
Sun D, Linghu B, Lu C, Wei B. Dual-Metal Organic Framework Nanozyme for Synergistic Photothermal-Chemodynamic Therapy: Copper-Molybdenum Synergism in Gastric Cancer Treatment. International Journal of Nanomedicine. 2026;Volume 21:1-16. doi:10.2147/ijn.s592877
BibTeX
@article{Sun2026,
author = {Sun, Dachuan and Linghu, Bimei and Lu, Canrong and Wei, Bo},
title = {Dual-Metal Organic Framework Nanozyme for Synergistic Photothermal-Chemodynamic Therapy: Copper-Molybdenum Synergism in Gastric Cancer Treatment},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--16},
doi = {10.2147/ijn.s592877}
}
EUVIMED